EastBio PhD: Burkholderia Host–Pathogen Research in 3D Human-Lung Models

EastBio PhD: Burkholderia Host–Pathogen Research in 3D Human-Lung Models

Quick Decision

This four-year Edinburgh PhD examines model validity and tissue context in three-dimensional human-lung research. The saved project advert names Dr M Moule and describes a worldwide funding competition; current acceptance status is not established by the saved materials. The advert links to the project eligibility checklist, whose body is not available in the saved evidence. Recruitment guidance supplies an application route, while the named award, 2027/28 stipend and route-specific overseas-fee coverage require written confirmation. Model training is valuable, but the independent thesis scope, recent supervisor-publication record, supervision and resources need clarification. Programme and entry rules; EASTBIO international funding policy

Research Question and Doctoral Work

The advert contrasts the simplicity of conventional in-vitro systems with the complexity of living tissue, and the difficulty of disentangling interacting components in whole organisms. Three-dimensional microtissues, organoid and organ-on-chip concepts provide additional research-model layers. Melioidosis, caused by B. pseudomallei, and severe infection provide the disease context; the advert specifies B. thailandensis as the model organism in modular human-lung models. Its advertised questions cover immune-cell involvement in Burkholderia dissemination, host factors involved in systemic spread, and how bacterial virulence factors relate to host cells and pathways involved in spread. These are open research questions, not established outcomes; model observations are not equivalent to complete human disease or a therapeutic recommendation. The doctoral work spans cell/tissue models, microbiology, molecular biology and analysis. The team advertises existing lung-model foundations, but the advert does not allocate personal samples, equipment or a complete thesis plan. At applicant level, the important intellectual task is evaluating what the model can explain about host–microbe relationships and what remains beyond its scope. A response observed in one cell population or tissue model is not equivalent to complete human disease. Potential research outputs are better interpreted as robust model-based evidence and clear limitations, not a promised treatment, vaccine or clinical test. The exact number of model comparisons, student responsibilities, analysis support and route to an independent thesis must be agreed. This is experimental cell/tissue-model research; no computation-only route or clinical patient responsibility is promised. The field offers training at the boundary between microbiology, cell biology and quantitative model interpretation. Its practical difficulty is balancing biological relevance with tractability and reproducibility. More realistic structure does not automatically establish predictive clinical value. The recent named-supervisor studies below demonstrate experience across model contexts, but do not independently validate this exact proposed human-lung/Burkholderia model. The transferable value is rigorous quantitative interpretation, critical comparison and collaborative biological research. The National Careers Service gives a broad UK biochemist occupation range of £28,000 starter–£53,000 experienced. It is a general labour-market reference, not this project’s placement record or a promised salary. Career evidence and its scope

School, Programme and Field Context

The degree-awarding institution is the University of Edinburgh, United Kingdom, and the academic home is the School of Biological Sciences, within the College of Science and Engineering. The current programme identifies King’s Buildings as its campus. Moule’s institutional affiliations do not establish a separate degree-awarding partner or confirm the exact project’s administrative institute. Confirm its host group and physical location through the exact project checklist or the School. Current programme The specified registration is Biological Sciences (with Internship) PhD,48 months full-time, starting 1 October 2027. The programme has a probationary first year, a thesis committee with an independent chair, and annual progression reviews. It specifies reports at 10 weeks and 10 months, a first-year oral presentation, a second-year poster and a third-year oral presentation. The final thesis is defended in a viva. These are programme rules; the second named supervisor and daily guidance arrangement for this project are not yet confirmed. Cohort training spans methods, research, professional and thematic skills. The advert includes a three-month placement; the programme describes PIPS up to three months, or up to six with approval. This title is not marked CASE and names no company: placement host, timing and expenses need confirmation. Exact programme and registration; Training framework The School’s REF 2021 Biological Sciences account reports 94% world-leading/internationally excellent research and 100% world-leading environment, with a UK-top-five subject claim. This is a dated national subject assessment, not a 2027 global ranking or a score for the individual lab. Research training is not a clinical qualification. Subject evidence and assessment year

Supervisors, Recent Primary Research and Resources

The institutional profile identifies Maddie Moule as Lecturer in Bacterial Pathogenesis; the official lab biography gives Madeleine Moule, Principal Investigator and Chancellor’s Fellow in Global Health. These are compatible forms/roles of the same researcher, not a male Matthew Moule or an invented professorship. Her microbiology/immunology doctorate at Stanford and subsequent LSHTM/Texas A&M work provide a respiratory-research trajectory. Current student load and daily supervision time are not published. Current role; Official biography The School announced a separate 2026 HFSP three-year $1.35 million research award involving Moule and collaborators at CNRS, Oxford and Waterloo. This is evidence of international collaborative activity, not an additional student stipend, automatic access to those hosts, a joint degree or proof that this exact studentship is underwritten by that grant. Actual grant announcement The available evidence for these three papers is limited to institutional abstracts and bibliographic records; for the 2022 paper it also includes publisher metadata and an equal-contribution note. Full texts, methods and supplementary materials were not assessed. Based on first-online dates, the 2024 and 2022 papers fall within five years; the 2021 paper is earlier context. None independently validates this exact doctoral model. Madeleine G. Moule; Aaron B. Benjamin; Melanie L. Buger; Claudine Herlan; Maxim Lebedev; Jennifer S. Lin; Kent J. Koster; Neha Wavare; Leslie G. Adams; Stefan Bräse; Ricardo Munoz-Medina; Carolyn L. Cannon; Annelise E. Barron; Jeffrey D. Cirillo. Peptide-mimetic treatment of Pseudomonas aeruginosa in a mouse model of respiratory infection. Communications Biology 7(1): 1033. DOI: 10.1038/s42003-024-06725-1. First online/published record: 22 August 2024; Moule is first listed. It provides adjacent model-based research experience, not proof of human efficacy or validation of this exact project. Institutional record Aaron B. Benjamin; Madeleine G. Moule; Maruti K. Didwania; Jonathan Hardy; Panatda Saenkham-Huntsinger; Preeti Sule; Josefine Eilsø Nielsen; Jennifer S. Lin; Christopher H. Contag; Annelise E. Barron; Jeffrey D. Cirillo. Efficacy of Cathelicidin-Mimetic Antimicrobial Peptoids against Staphylococcus aureus. Microbiology Spectrum 10(3): e00534-22. DOI: 10.1128/spectrum.00534-22. Published online 25 April 2022; issue dated 29 June 2022. Moule is second listed and an equal-contribution author with Benjamin; alphabetical order is stated by the publisher. This is adjacent preclinical research, not this project’s model validation or clinical advice. Institutional record Publisher history and authors Ryan J. Smith; Madeleine G. Moule; Pablo A. Leon; Ethan T. Iverson; Thomas J. Kolibaba; Jeffrey D. Cirillo; Jaime C. Grunlan. Polyelectrolyte Complex that Minimizes Bacterial Adhesion to Polyester. Macromolecular Materials and Engineering 306(12): 2100579. DOI: 10.1002/mame.202100579. Early online 2 September 2021; institutional issue/publication record 16 December 2021. Moule is second listed; Jaime C. Grunlan is marked corresponding. The early-online date is outside the strict five-year window. Its materials context does not validate human tissue or this project. Institutional record The School’s shared microscopy, flow/omics and analytical services support a credible environment, but do not establish a personal allocation or approved human-tissue access. Ask for the actual analysis support, training, supervisory backup and institutional governance responsibilities attached to this project. Do not infer animal or patient work from a supervisor’s previous paper. Shared resources

Funding and International Costs

The current exact advert describes a four-year funded competition for either an EASTBIO BBSRC Doctoral Landscape Award or an Edinburgh Doctoral College Award (EDC), with UKRI-standard stipend, tuition cover, project-cost support and mandatory training including a three-month placement. No separate EDC application is required. International applicants can compete; eligibility is not a personal award. The linked EASTBIO FAQ states that UKRI’s 30% cap concerns EASTBIO’s annual international intake, not an applicant’s probability, and that successful international EASTBIO candidates have a tuition top-up waiver. These EASTBIO provisions must not automatically be applied to the separate EDC route. The saved materials do not establish whether EastBio or EDC covers visa or IHS costs; confirm this for the named award alongside tuition coverage, stipend, funded period and other exclusions. The exact project eligibility checklist is linked from the advert, but its body is unavailable in the saved materials. School funding routes The School describes EDC support as tuition plus a four-year stipend and project grant £5,000 in years 1–3 and £1,000 in year 4: £16,000 total research support, not extra living income. UKRI's confirmed 2026/27 minimum is £21,805 stipend and £5,238 home-fee contribution; the 2027/28 rate is not yet given there. EDC grant scope; Confirmed current UKRI reference The university estimates 2026/27 living costs £18,504/year or £1,542/month, calculated March 2026: accommodation/utilities £978, food/shopping £248, mobile £12, social/leisure/wellbeing £246, bus (age 22+) £58 monthly. Accommodation/utilities illustrations range £752–£1,249/month; the lower private figure is based on a room-share calculation, not a private whole-flat quote or guaranteed place. The £21,805 stipend benchmark and £18,504 living-cost estimate relate to 2026/27 and serve different purposes. They do not establish an individual 2027/28 budget. The future stipend, chosen accommodation, travel, deposits and immigration costs must be checked separately. Current budget methodology Current Student visa application fee is £558, and student IHS is £776/yearwith partial-year charging rules. If chargeable permission were 4.5 years, the IHS example would be £3,492, or £4,050 with the application fee; actual CAS/permission duration and future rates determine the bill. The outside-London visa maintenance figure £1,171/month for up to 9 months (£10,539) is a regulatory evidence threshold, not a full-year Edinburgh budget. Sponsorship/CAS and Chinese differential-evidence arrangements require individual checking. Travel, deposits and cash before the first stipend remain separate. Visa fee; IHS rules; Maintenance evidence

Background, Language and Application

The project advert does not specify additional mandatory prior techniques, a project-specific degree classification beyond programme rules, or a separate English threshold. Cell biology, microbiology, molecular analysis and quantitative interpretation are sensible preparation areas, not invented hard prerequisites. The programme normally expects a relevant UK 2.1 or international equivalent, some research experience and good understanding of the proposed field. Relevant industrial experience may partly meet the research-experience expectation; non-standard backgrounds are assessed case by case. EastBio does not generally require a master’s. The programme’s China selector requires a degree from a recognised Chinese university or its Priority List. Its displayed percentage table is explicitly scoped to postgraduate taught programmes and two named MScR programmes; do not apply those 80–85% figures automatically to this PhD. The PhD note defers any master’s requirement to this programme’s Qualifications section, which currently specifies a relevant 2:1 or international equivalent without a separate master’s requirement. Ask admissions to assess the specific qualification. Mentioned methods are not automatically pre-entry requirements. Actual degree requirements For 2027 entry, the programme specifies IELTS 6.5 overall/6.0 each, without One Skill Retake. TOEFL taken before 21 January 2026 uses 92 overall/23 each; from that date the new scale requires 4.5 overall/4.5 each, without MyBest aggregation. IELTS, TOEFL and the two Oxford tests must be no more than two years old on the first day of the entry month; other accepted tests have a three-and-a-half-year limit. An English-taught and assessed degree must meet the country/approved-university conditions and, for a non-majority-English-country national, be no more than five years old. Check alternative qualifications on the programme page. Non-English academic records require originals plus official translations. An application may precede the English test, but final offer conditions still apply. Student-visa holders must register full-time and live within commuting distance; individual ATAS/CAS conditions must be checked. 2027 language criteria; International study conditions Only one EastBio project across all hosts may be selected. Contact the named supervisors, prepare the 2027 EastBio form, transcripts, anonymous EDI-survey response ID, and two references using the official form. Referees can be academic/professional but cannot be the project supervisors. Extra documents such as CVs are disregarded in the formal process; an informal supervisor contact is distinct. The programme charges no application fee. Mandatory application materials; Document rules Submit through EUCLID for Biological Sciences with Internship, selecting 1 October 2027, and provide the exact title, supervisor and anticipated funding route. Upload the EASTBIO form in the Research Proposal section; this label does not itself require an extra experimental proposal. The current exact advert states midday Monday 16 November 2026, without a timezone, and accepts references up to two weeks later. The central policy requests both template references by 16 November and warns that missing references disadvantage shortlisting. Submit everything by the main deadline where possible and obtain written host confirmation before relying on the grace period. Do not silently convert midday to 23:59 or assign a verified timezone. EUCLID’s automated referee invitation does not remove the template requirement. Central application rules; Reference policy; Exact checklist The project instructions keep applications under consideration until 22 February 2027, request missing information through Euclid, and reserve amendment/withdrawal of scholarships. Check the portal and email. Central dates are 18 January nominations,22 February interview invitations, week beginning 8 March interviews, week beginning 22 March decisions, with 1 October entry. These are selection stages, not an interview or award promise. Current selection timetable

Next Actions and Questions by Stage

Before applying: choose the single project; confirm degree equivalence, English evidence and the host’s reference deadline. The saved advert provides the stated deadline, but the official project checklist body and its consistency with the central reference policy remain unconfirmed. At interview: Define the independent thesis and what evidence will justify model relevance without overclaiming human prediction. Confirm daily supervision, training, analytical support, approved work responsibilities and ordinary placement. Ask which existing model foundations and preliminary evidence are available to the student, and how a thesis remains viable if the model has limited generality. Before accepting: obtain the named award, 2027 stipend and international fee terms in writing; confirm research/placement expenses, funded period and completion arrangements. Check the supervision/committee agreement, individual CAS/ATAS conditions, housing, arrival cash and whether the named award covers visa/IHS costs. Neither shared facilities nor a supervisor’s publication/grant record guarantees personal access, current supervisory capacity or career outcomes.

Evidence and Sources

• EASTBIO current official application and delegated project directory
• EASTBIO current eligibility and overseas fee waiver
• EASTBIO selection and timeline
• EASTBIO training structure
• Edinburgh Biological Sciences REF 2021 subject context
• Biological Sciences with Internship current 2027 programme
• SBS 2027 current EASTBIO and EDC funding
• Edinburgh postgraduate living costs 2026/27
• UKRI current stipend and fee minima
• UK Student visa current application fee
• UK student health surcharge
• UK outside-London maintenance evidence
• National Careers Service biological scientist careers
• Madeleine Moule institutional role and publication record
• Maddie Moule official lab biography
• 2026 HFSP institutional funding announcement
• Moule et al 2024 respiratory-model primary research
• Benjamin et al 2022 preclinical primary study
• Smith et al 2021 antifouling-material primary study
• School and institute organisation
• School shared imaging and analytical facilities